A comprehensive view of Cardiovascular / Heart Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.
J&J MedTech's CERENOVUS launches the TRUFILL n-BCA Liquid Embolic System Procedural Set, a new solution for treating hemorrhagic stroke that simplifies procedure preparation; the product received FDA approval on September 29, 2023
Published:
March 28, 2024
by Biosense Webster Inc.
|
Novartis Canada disagrees with CADTH's draft recommendations not to reimburse LEQVIO for hypercholesterolemia treatment in Canada; Novartis claims LEQVIO has aided over 178,000 patients, including 2,000 Canadians, since 2022
Published:
March 26, 2024
by Contify Life Science News
|
Novo Nordisk A/S bolsters heart disease treatment pipeline with strategic acquisition of Cardior Pharmaceuticals
Published:
March 25, 2024
by Industry Intelligence Inc.
|
AstraZeneca launches Healthy Heart Africa 2.0 in Ghana to combat non-communicable diseases, particularly cardiovascular ailments; the initiative underscores a shift from treatment to prevention, emphasizing early screening, diagnosis, and treatment
Published:
March 25, 2024
by Business and Financial Times (Ghana)
|
Abbott gets CE Mark approval for Bluetooth-enabled Assert-IQ insertable cardiac monitor in Europe; device offers the world's longest battery life and allows physicians to monitor patients' heart rhythms remotely for up to six years
Published:
March 25, 2024
by Abbott Laboratories
|
Ask us about our Government & Public Policy market view